...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion.
【24h】

Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion.

机译:血管紧张素-(1-7):在心肌缺血/再灌注中的心脏保护作用。

获取原文
获取原文并翻译 | 示例

摘要

In this study we evaluate the effects of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts. Rat hearts were perfused according to Langendorff technique and maintained in heated (37+/-1 degrees C) and continuously gassed (95% O(2)/5% CO(2)) Krebs-Ringer solution at constant pressure (65 mm Hg). The electrical activity was recorded with an ECG (bipolar). Local ischemia was induced by coronary ligation for 15 minutes. After ischemia, hearts were reperfused for 30 minutes. Cardiac arrhythmias were defined as the presence of ventricular tachycardia and/or ventricular fibrillation after the ligation of the coronary artery was released. Angiotensin II (0.20 nmol/L, n=10) produced a significant enhancement of reperfusion arrhythmias. On the other hand, Ang-(1-7) presented in the perfusion solution (0.22 nmol/L, n=11) reduced incidence and duration of arrhythmias. The antiarrhythmogenic effects of Ang-(1-7) was blocked by the selective Ang-(1-7) antagonist A-779 (2 nmol/L, n=9) and by indomethacin pretreatment (5 mg/kg IP, n=8) but not by the bradykinin B(2) antagonist HOE 140 (100 nmol/L, n=10) or by L-NAME pretreatment (30 mg/kg IP, n=8). These results suggest that the antiarrhythmogenic effect of low concentrations of Ang-(1-7) is mediated by a specific receptor and that release of endogenous prostaglandins.by Ang-(1-7) contributes to the alleviation of reversible and/or irreversible ischemia-reperfusion injury.
机译:在这项研究中,我们评估了血管紧张素-(1-7)对离体大鼠心脏再灌注心律不齐的影响。根据Langendorff技术灌注大鼠心脏,并在恒定压力(65 mm Hg)下保持加热(37 +/- 1摄氏度)和连续充气(95%O(2)/ 5%CO(2))Krebs-Ringer溶液)。用ECG(双极)记录电活动。通过冠状动脉结扎15分钟诱导局部缺血。缺血后,将心脏再灌注30分钟。心脏心律失常定义为释放冠状动脉结扎后出现室性心动过速和/或室颤。血管紧张素II(0.20 nmol / L,n = 10)显着增强了再灌注性心律失常。另一方面,灌注溶液中的Ang-(1-7)(0.22 nmol / L,n = 11)降低了心律不齐的发生率和持续时间。选择性Ang-(1-7)拮抗剂A-779(2 nmol / L,n = 9)和吲哚美辛预处理(5 mg / kg IP,n =)阻断了Ang-(1-7)的抗心律失常作用。 8),但不使用缓激肽B(2)拮抗剂HOE 140(100 nmol / L,n = 10)或L-NAME预处理(30 mg / kg IP,n = 8)。这些结果表明低浓度Ang-(1-7)的抗心律失常作用是由特定受体介导的,Ang-(1-7)释放内源性前列腺素有助于缓解可逆和/或不可逆缺血。再灌注损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号